Librax (Valeant Pharmaceuticals International)
Welcome to the PulseAid listing for the Librax drug offered from Valeant Pharmaceuticals International. This Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient],Anticholinergic [EPC],Decreased Parasympathetic Acetylcholine Activity [PE],GI Motility Alteration [PE],Digestive/GI System Activity Alteration [PE],Cholinergic Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Valeant Pharmaceuticals International |
| NON-PROPRIETARY NAME: | Chlordiazepoxide Hydrochloride and Clidinium Bromide |
| SUBSTANCE NAME: | CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient],Anticholinergic [EPC],Decreased Parasympathetic Acetylcholine Activity [PE],GI Motility Alteration [PE],Digestive/GI System Activity Alteration [PE],Cholinergic Antagonists [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1966-09-01 |
| END MARKETING DATE: | 0000-00-00 |
Librax HUMAN PRESCRIPTION DRUG Details:
| Item Description | Librax from Valeant Pharmaceuticals International |
| LABELER NAME: | Valeant Pharmaceuticals International |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5; 2.5(mg/1; mg/1) |
| START MARKETING DATE: | 1966-09-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0187-4100_0fbbaace-b922-44ba-86cb-1310ee6c4597 |
| PRODUCT NDC: | 0187-4100 |
| APPLICATION NUMBER: | NDA012750 |
Other CHLORDIAZEPOXIDE HYDROCHLORIDE; CLIDINIUM BROMIDE Pharmaceutical Manufacturers / Labelers:
